BRADLEY ROSSIN — Lobbyist Profile | Poliscope

BRADLEY ROSSIN

Filings

Clients

Firms

Years active

2026–2026

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
GENMAB US, INC.	2	2026

Firm	Filings	Years
GENMAB US, INC.	2	2026

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

2026 · third_quarter · Q3

Firm income: —Client expense: $160,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Most Favored Nation Prescription Drug User Fee Act 340B Drug Pricing Program

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

2026 · third_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗